首页NVTAQ • OTCMKTS
add
Invitae Corp
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2023年9月info | 年同比变化 |
|---|---|---|
收入 | 1.21亿 | -9.21% |
经营支出 | 1.42亿 | -21.71% |
净收入 | -9.42亿 | -212.83% |
净利润率 | -777.05 | -244.56% |
每股收益 | -0.10 | 76.19% |
息税折旧摊销前利润 | -7115.80万 | 42.73% |
有效税率 | 0.65% | — |
资产负债表
总资产
负债总额
| (USD) | 2023年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2.55亿 | -56.55% |
总资产 | 5.35亿 | -73.59% |
负债总额 | 16.19亿 | -13.33% |
权益总额 | -10.83亿 | — |
发行在外的股份 | 2.86亿 | — |
市净率 | -0.00 | — |
资产回报率 | -25.00% | — |
资本回报率 | -28.48% | — |
现金流
现金净变动
| (USD) | 2023年9月info | 年同比变化 |
|---|---|---|
净收入 | -9.42亿 | -212.83% |
来自运营的现金 | -6689.50万 | 48.02% |
投资现金 | 511.70万 | -88.32% |
融资现金 | -338.10万 | -99.94% |
现金净变动 | -6515.90万 | 24.76% |
自由现金流 | -2945.92万 | -38.14% |
简介
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012.
In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.
In early 2024, Invitae filed for Chapter 11 bankruptcy protection, and later announced an agreement for an acquisition by Labcorp. Wikipedia
成立时间
2010
员工数量
1,700
